Page last updated: 2024-11-07

cdri 85-287

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

CDRI 85-287: structure given in first source; an antiestrogen and antiimplantation agent [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID159508
CHEMBL ID27283
SCHEMBL ID6669000
MeSH IDM0182783

Synonyms (16)

Synonym
nsc607873
nsc-607873
cdri 85-287
cdri-85-287
2-(4-(2-piperidinoethoxy)phenyl)-3-phenyl-2h-1-benzopyran
cdri-85/287
1-(2-(4-(3-phenyl-2h-1-benzopyran-2-yl)phenoxy)ethyl)piperidine
piperidine, 1-(2-(4-(3-phenyl-2h-1-benzopyran-2-yl)phenoxy)ethyl)-
2-(4-(2-n-piperidino)ethoxyphenyl)-3-phenyl(2h)benzo(b)pyran
CHEMBL27283
130064-18-5
1-[2-[4-(3-phenyl-2h-chromen-2-yl)phenoxy]ethyl]piperidine
SCHEMBL6669000
DTXSID30926582
1-{2-[4-(3-phenyl-2h-1-benzopyran-2-yl)phenoxy]ethyl}piperidine
PD162080

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"5 mg/kg body weight) of the compound administered on days 1, 2 or 3 of pregnancy or multiple dosing (0."( Biological profile of 2-[4-(2-N-piperidinoethoxy) phenyl]-3-phenyl (2H) benzo (b) pyran--a potent antiimplantation agent in rat.
Dhar, JD; Duran, S; Kapil, RS; Setty, BS, 1991
)
0.28
" This was prevented by ormeloxifene and the effect, though apparently more in females supplemented with higher dose of ormeloxifene, was not always significantly different and clear dose-response was not evident until BMD data was evaluated on T-/Z-score basis."( In vitro anti-resorptive activity and prevention of ovariectomy-induced osteoporosis in female Sprague-Dawley rats by ormeloxifene, a selective estrogen receptor modulator.
Arshad, M; Ghosh, R; Sawlani, V; Sengupta, S; Sharma, S; Singh, MM, 2004
)
0.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (12)

Assay IDTitleYearJournalArticle
AID186399Antiestrogenic activity in presence of unlabeled estradiol as mean uterine weight in rats after 0.3 ug dose1990Journal of medicinal chemistry, Dec, Volume: 33, Issue:12
Structure-activity relationship of antiestrogens. Effect of the side chain and its position on the activity of 2,3-diaryl-2H-1-benzopyrans.
AID38726Relative binding affinity against Antiestrogen binding site(AEBS)1990Journal of medicinal chemistry, Dec, Volume: 33, Issue:12
Structure-activity relationship of antiestrogens. Phenolic analogues of 2,3-diaryl-2H-1-benzopyrans.
AID70669Mean percent inhibition of Estrogen receptor beta in rat1990Journal of medicinal chemistry, Dec, Volume: 33, Issue:12
Structure-activity relationship of antiestrogens. Effect of the side chain and its position on the activity of 2,3-diaryl-2H-1-benzopyrans.
AID187060Estrogenic activity as mean uterine weight in rats on 10 ug dose1990Journal of medicinal chemistry, Dec, Volume: 33, Issue:12
Structure-activity relationship of antiestrogens. Phenolic analogues of 2,3-diaryl-2H-1-benzopyrans.
AID38725Relative binding affinity against Antiestrogen binding site(AEBS)1990Journal of medicinal chemistry, Dec, Volume: 33, Issue:12
Structure-activity relationship of antiestrogens. Effect of the side chain and its position on the activity of 2,3-diaryl-2H-1-benzopyrans.
AID187059Antiestrogenic activity in presence of unlabeled estradiol as mean uterine weight in rats at 0.3 ug dose1990Journal of medicinal chemistry, Dec, Volume: 33, Issue:12
Structure-activity relationship of antiestrogens. Phenolic analogues of 2,3-diaryl-2H-1-benzopyrans.
AID69530Relative binding affinity against estrogen receptor(ER)1990Journal of medicinal chemistry, Dec, Volume: 33, Issue:12
Structure-activity relationship of antiestrogens. Effect of the side chain and its position on the activity of 2,3-diaryl-2H-1-benzopyrans.
AID69512Relative binding affinity(RBA) against Estrogen receptor in rat liver1992Journal of medicinal chemistry, Apr-17, Volume: 35, Issue:8
Synthesis of 2-(p-chlorobenzyl)-3-aryl-6-methoxybenzofurans as selective ligands for antiestrogen-binding sites. Effects on cell proliferation and cholesterol synthesis.
AID186407Estrogenic activity as mean uterine weight in rats on 10 ug dose1990Journal of medicinal chemistry, Dec, Volume: 33, Issue:12
Structure-activity relationship of antiestrogens. Effect of the side chain and its position on the activity of 2,3-diaryl-2H-1-benzopyrans.
AID69688Relative binding affinity against estrogen receptor(ER)1990Journal of medicinal chemistry, Dec, Volume: 33, Issue:12
Structure-activity relationship of antiestrogens. Phenolic analogues of 2,3-diaryl-2H-1-benzopyrans.
AID185420Percent inhibition of estradiol stimulated uterine growth in rats1990Journal of medicinal chemistry, Dec, Volume: 33, Issue:12
Structure-activity relationship of antiestrogens. Phenolic analogues of 2,3-diaryl-2H-1-benzopyrans.
AID38618Relative binding affinity(RBA) against AEBS (Antiestrogen binding site) in rat liver1992Journal of medicinal chemistry, Apr-17, Volume: 35, Issue:8
Synthesis of 2-(p-chlorobenzyl)-3-aryl-6-methoxybenzofurans as selective ligands for antiestrogen-binding sites. Effects on cell proliferation and cholesterol synthesis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's18 (81.82)18.2507
2000's1 (4.55)29.6817
2010's3 (13.64)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other22 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]